Brainstorm Cell Therapeutics Inc (BCLI)

Brainstorm Cell Therapeutics Inc (BCLI) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $9.2M; returns 1 day -1.3%, 1 week -2.6%, 1 year +9.7%.

Brainstorm Cell Therapeutics Inc. is a clinical-stage biotechnology company focused on developing autologous adult stem cell therapies for debilitating neurodegenerative diseases. The company currently generates no revenue, as its entire business model is centered on the research, development, and potential future commercialization of its proprietary NurOwn® technology platform.

Groups BCLI belongs to

• Biotechnology
• Clinical Stage Biotech
• Autologous Cell Therapy
• Healthcare
• Clinical Stage
• Neuroscience
• Regenerative Medicine
• Neurological Disorders
• Rare Diseases
• Unmet Medical Needs
• R&D

BCLI financial model: income statement, cash flow and balance sheet